Calibration between the Estimated Probability of the Risk Assessment Chart of Japan Atherosclerosis Society and Actual Mortality Using External Population: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN)

Journal of Atherosclerosis and Thrombosis
Michikazu NakaiEPOCH-JAPAN Research Group

Abstract

In Japan Atherosclerosis Society guidelines for the prevention of atherosclerotic cardiovascular diseases 2012 (JAS2012), NIPPON DATA80 risk assessment chart (ND80RAC) was adopted to estimate the 10-year probability of coronary artery disease (CAD) mortality. However, there was no comparison between the estimated mortality calculated by ND80RAC and actual mortality in external populations. Accordingly, we used the large pooled database of cohorts in Japan, EPOCH-JAPAN, as an external population. The participants of EPOCH-JAPAN without a history of cardiovascular disease (15,091 men and 18,589 women aged 40-74 years) were analyzed based on sex. The probability of a 10-year risk of CAD/stroke mortality was estimated by ND80RAC. The participants were divided into both decile of their estimated mortality and three categories according to JAS2012. The calibration between the mean estimated mortality and the actual mortality was performed by the Hosmer and Lemeshow (H-L) test. In both sexes, the estimated CAD mortality was higher than the actual mortality, particularly in higher deciles of estimated mortality, and the estimated stroke mortality was almost concordant with the actual mortality in low/moderate deciles of estimated morta...Continue Reading

References

Nov 10, 1992·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·N Yamada
Jan 5, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·M SukaK Yoshida
Jan 17, 2002·Diabetologia·M PortaUNKNOWN EURODIAB Prospective Complications Study Group
Dec 4, 2003·BMJ : British Medical Journal·Peter BrindleShah Ebrahim
Sep 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·UNKNOWN NIPPON DATA80 Research Group
Apr 30, 2008·Hypertension·Yoshitaka MurakamiUNKNOWN Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Research Group (EPOCH-JAPAN)
Mar 7, 2009·Journal of Epidemiology·Shizukiyo IshikawaUNKNOWN Jichi Medical School (JMS) Cohort Study Group
Mar 7, 2009·Journal of Epidemiology·Masatoshi MatsumotoUNKNOWN Jichi Medical School (JMS) Cohort Study Group
Sep 19, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hisatomi ArimaYutaka Kiyohara
Jan 8, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ivanny MarchantFrançois Gueyffier
Feb 27, 2010·American Journal of Hypertension·Daisaku YasuiYutaka Imai
Jun 8, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Naohito TanabeUNKNOWN Japan Arteriosclerosis Longitudinal Study Group
Nov 30, 2010·Preventive Medicine·Yoshitaka MurakamiUNKNOWN EPOCH-JAPAN Research Group
Jun 29, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Akira FujiyoshiUNKNOWN Observational Cohorts in Japan (EPOCH-JAPAN) Research Group
Nov 24, 2012·Ophthalmology·Ryo KawasakiUNKNOWN Japan Diabetes Complications Study Group
Jan 15, 2013·Journal of the American Heart Association·Sin-ya NagasawaUNKNOWN Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN) Research Group
Sep 17, 2013·PloS One·Luis M Artigao-RodenasUNKNOWN Grupo de Enfermedades Vasculares de Albacete (GEVA)
Nov 14, 2013·Journal of the American Pharmacists Association : JAPhA
Mar 19, 2014·Hypertension·Kei AsayamaUNKNOWN Evidence for Cardiovascular Prevention From Observational Cohorts in Japan (EPOCH-JAPAN) Research Group
Jul 30, 2014·International Journal of Cardiology·Sharmini SelvarajahMichiel L Bots
Jan 21, 2015·Hypertension·Michihiro SatohUNKNOWN Evidence for Cardiovascular Prevention From Observational Cohorts in Japan (EPOCH–JAPAN) Research Group*

❮ Previous
Next ❯

Citations

Sep 7, 2017·Journal of Hypertension·Kei AsayamaUNKNOWN Evidence for Cardiovascular Prevention From Observational Cohorts in Japan (EPOCH-JAPAN) Research Group
Aug 24, 2018·Journal of Atherosclerosis and Thrombosis·Makoto KinoshitaUNKNOWN Committee for Epidemiology and Clinical Management of Atherosclerosis
Jul 4, 2020·Annals of Human Biology·Hao ZhuXingguang Zhang
Aug 2, 2017·Journal of Atherosclerosis and Thrombosis·Nusrat S Shommu, Tanvir C Turin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Circulation Journal : Official Journal of the Japanese Circulation Society
NIPPON DATA80 Research Group
Circulation Journal : Official Journal of the Japanese Circulation Society
Yasuyuki NakamuraNippon Data 80 Research Group
Circulation Journal : Official Journal of the Japanese Circulation Society
Junko TamakiNIPPON DATA80 Research Group
Nihon rinsho. Japanese journal of clinical medicine
Hirotsugu Ueshima
© 2021 Meta ULC. All rights reserved